Milner P - Search Results

1

Antithrombotic activity of the novel oral anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in animal models.

Bowersox SS, Canafax D, Druzgala P, Milner P, Weitz JI. Bowersox SS, et al. Among authors: milner p. Thromb Res. 2010 Nov;126(5):e383-8. doi: 10.1016/j.thromres.2010.08.025. Thromb Res. 2010. PMID: 20869102

2

Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.

Albrecht D, Ellis D, Canafax DM, Combs D, Druzgala P, Milner PG, Midei MG. Albrecht D, et al. Among authors: milner pg. Thromb Haemost. 2017 Apr 3;117(4):706-717. doi: 10.1160/TH16-08-0623. Epub 2017 Feb 9. Thromb Haemost. 2017. PMID: 28180234 Clinical Trial.

3

The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation.

Ellis DJ, Usman MH, Milner PG, Canafax DM, Ezekowitz MD. Ellis DJ, et al. Circulation. 2009 Sep 22;120(12):1029-35, 2 p following 1035. doi: 10.1161/CIRCULATIONAHA.109.856120. Epub 2009 Sep 8. Circulation. 2009. PMID: 19738136 Clinical Trial.

4

A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin. The EmbraceAC Trial.

Whitlock RP, Fordyce CB, Midei MG, Ellis D, Garcia D, Weitz JI, Canafax DM, Albrecht D, Milner PG. Whitlock RP, et al. Among authors: milner pg. Thromb Haemost. 2016 Aug 1;116(2):241-50. doi: 10.1160/TH15-11-0910. Epub 2016 May 12. Thromb Haemost. 2016. PMID: 27173100 Clinical Trial.

5

Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants.

Bavisotto LM, Ellis DJ, Milner PG, Combs DL, Irwin I, Canafax DM. Bavisotto LM, et al. J Clin Pharmacol. 2011 Apr;51(4):561-74. doi: 10.1177/0091270010370588. Epub 2010 Jul 9. J Clin Pharmacol. 2011. PMID: 20622200 Clinical Trial.

6

A randomized trial of budiodarone in paroxysmal atrial fibrillation.

Ezekowitz MD, Nagarakanti R, Lubinski A, Bandman O, Canafax D, Ellis DJ, Milner PG, Ziola M, Thibault B, Hohnloser SH; PASCAL Investigators. Ezekowitz MD, et al. J Interv Card Electrophysiol. 2012 Jun;34(1):1-9. doi: 10.1007/s10840-011-9636-3. Epub 2011 Dec 29. J Interv Card Electrophysiol. 2012. PMID: 22205496 Clinical Trial.

7

Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease.

Albrecht D, Turakhia MP, Ries D, Marbury T, Smith W, Dillon D, Milner PG, Midei MG. Albrecht D, et al. Among authors: milner pg. Thromb Haemost. 2017 Nov;117(11):2026-2033. doi: 10.1160/TH16-10-0815. Epub 2017 Nov 30. Thromb Haemost. 2017. PMID: 28933798 Clinical Trial.

8

A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology.

Arya A, Silberbauer J, Teichman SL, Milner P, Sulke N, Camm AJ. Arya A, et al. Among authors: milner p. Europace. 2009 Apr;11(4):458-64. doi: 10.1093/europace/eun384. Epub 2009 Jan 26. Europace. 2009. PMID: 19174378 Free PMC article. Clinical Trial.

9

Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy.

Milner PG, Dimarco JP, Lerman BB. Milner PG, et al. Pacing Clin Electrophysiol. 1988 May;11(5):562-8. doi: 10.1111/j.1540-8159.1988.tb04551.x. Pacing Clin Electrophysiol. 1988. PMID: 2456534

10

Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest.

Milner PG, Platia EV, Reid PR, Griffith LS. Milner PG, et al. Am J Cardiol. 1985 Oct 1;56(10):588-92. doi: 10.1016/0002-9149(85)91016-1. Am J Cardiol. 1985. PMID: 4050692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters